☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Amneal Pharmaceuticals
Amneal and Zambon Biotech Sign an Exclusive Licensing Agreement for IPX203 to Treat Parkinson’s Disease (PD)
February 28, 2024
Amneal Pharmaceuticals’s Releuko (biosimilar, filgrastim) Receives the US FDA’s Approval of BLA for the Treatment of Neutropenia
February 28, 2022
Top 20 Generics Pharma Companies Based On 2019 Revenue
December 10, 2020
Top 20 Generics Pharma Companies Based On 2018 Revenue
September 13, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
